Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 6/20 | 0.52 |
| ▸ | GSTP1 | P09211 | 5/20 | 0.41 |
| ▸ | GSTA2 | P09210 | 3/20 | 0.39 |
| ▸ | GSTM1 | P09488 | 3/20 | 0.39 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.36 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.36 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.36 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.36 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30251768 | 1.00 | BCHE (0.52) | BCHEGSTP1GSTA2GSTM1SSTR1 | |
| SCHEMBL14094693 | 0.76 | GSTP1 (0.51) | BCHEGSTP1GSTA2GSTM1SSTR1 | |
| SCHEMBL5017349 | 0.76 | GSTP1 (0.51) | BCHEGSTP1GSTA2GSTM1SSTR1 | |
| SCHEMBL15132617 | 0.73 | GSTP1 (0.48) | BCHEGSTP1GSTA2GSTM1SSTR1 | |
| SCHEMBL7149762 | 0.70 | SSTR1 (0.42) | BCHEGSTP1SSTR1SSTR2SSTR4 | |
| SCHEMBL8062413 | 0.70 | SSTR1 (0.45) | BCHESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL7152284 | 0.69 | SSTR1 (0.46) | BCHESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL7156237 | 0.69 | SSTR1 (0.46) | BCHESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL7151934 | 0.69 | SSTR1 (0.46) | BCHESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL7153007 | 0.69 | SSTR1 (0.46) | BCHESSTR1SSTR2SSTR4SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250034197-A1 | NUCLEOSIDE-DIPHOSPHATE-HEPTOSE COMPOUNDS FOR TREATING CONDITIONS ASSOCIATED WITH ALPK1 ACTIVITY | PYROTECH (BEIJING) BIOTECHNOLOGY CO., LTD. (CN) | 2025-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250034197-A1 | NUCLEOSIDE-DIPHOSPHATE-HEPTOSE COMPOUNDS FOR TREATING CONDITIONS ASSOCIATED WITH ALPK1 ACTIVITY | PHKA1, PHKA2, ENTPD5 | BCHE 2564/4885GSTP1 2979/4885GSTA2 3245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.